Confirm changes
Please review and confirm your changes below.
Please validate captcha
Are you an employee of this fund ?
Add your professional email address below for verification
This email address seems invalid, please retry.
Overview
| Who we are | As a subsidiary of leading Swiss health insurance provider Helsana, we have been investing in start-ups and venture funds in digital health across Europe since 2021. Our goal is to improve efficiency and the provision of care in the Swiss healthcare system. |
| Value add | Helsana has a greater presence in Switzerland’s health insurance sector than any other insurer: 1.4 million people and 60,000 corporate clients are insured with Helsana. Our portfolio companies receive insights, access to the ecosystem and the opportunity to collaborate with Helsana and its partners. |
| Firm type | Corporate VC |
| Global HQ | Zürichstrasse 130, Dübendorf, 8600, CH |
| Branch office #1 | |
| Branch office #2 | |
| Branch office #3 | |
| Branch office #4 | |
| Branch office #5 |
Thesis
| Funding requirements | We invest in start-ups that improve patients’ access to healthcare. We invest in companies that can demonstrate traction with a scalable business model and are already active in or want to enter the Swiss market. Fund volume: CHF 100 million (Evergreen) Stage: Series A to B Initial ticket size: CHF 1–5 million Geography: Europe, with a focus on DACH, Benelux and the Nordics Our connection to an insurer means that we may also invest in companies in the fields of fintech, insurtech or cybersecurity. What’s out of scope? Everything that’s clearly too early, too late, too small or too big. We don’t invest in biotechnology, life sciences or pharma. |
| Funding stages | 3. Early Revenue4. Scaling |
| Lead | Sometimes |
| Check size | $1M to $5M |
| Target countries |  Germany Austria Switzerland France Italy Netherlands Belgium UK Denmark Sweden Norway Poland Spain Portugal |
Settings
| How to get in touch | Email address |
| Default email or URL to receive deal flow | |
| CRM | |
| https://www.linkedin.com/company/helsana-healthinvest/ | |
| Website | https://www.helsana.ch/en/helsana-group/about-us/healthinvest.html |
Do you fit this investor's criteria ?
We invest in start-ups that improve patients’ access to healthcare. We invest in companies that can demonstrate traction with a scalable business model and are already active in or want to enter the Swiss market. Fund volume: CHF 100 million (Evergreen) Stage: Series A to B Initial ticket size: CHF 1–5 million Geography: Europe, with a focus on DACH, Benelux and the Nordics Our connection to an insurer means that we may also invest in companies in the fields of fintech, insurtech or cybersecurity. What’s out of scope? Everything that’s clearly too early, too late, too small or too big. We don’t invest in biotechnology, life sciences or pharma.